Our Stories
Featured
Spotlight
CAMCEVI® (leuprolide) 42mg injection emulsion, FDA Approved for Treatment of Advanced Prostate Cancer, Available Exclusively at Biologics by McKesson
CARY, N.C., June 19, 2024—Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease areas, has been selected by Accord BioPharma, Inc. as an exclusive specialty pharmacy provider for CAMCEVI (leuprolide) 42mg injection...
Employee Voices
Improving Oncology Patient Outcomes: The Future of Risk-Based Care
Ela Lourido, Vice President and General Manager, Specialty Pharmacy ServicesResearch shows that Biologics by McKesson’s pioneering risk-based care program maximizes patients’ time on therapy, leading to better oncology patient outcomes. Now, its partnership with Arine...
Carcinoid Cancer Foundation Q&A
What is the Carcinoid Cancer Foundation? The Carcinoid Cancer Foundation (CCF), created in 1968, is the oldest neuroendocrine cancer foundation in the United States, and to the best of our knowledge, in the entire world. The Foundation’s mission is threefold: to...
Aplastic Anemia/MDS International Foundation Q&A
What is the Aplastic Anemia and MDS International Foundation? The Aplastic Anemia and MDS International Foundation (AAMDSIF) is dedicated to assisting and supporting people who have bone marrow disorders, including aplastic anemia, myelodysplastic syndrome and...
Business Insights
Video Transcript: Risk-Based Care: Personalized care for better patient outcomes
Risk-Based Care: Personalized care for better patient outcomes Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, Biologics by McKesson: When patients are referred to Biologics by McKesson, it's during one of the worst times of their lives. It's so...
Video Transcript: Risk-Based Care: Personalized care for better outcomes | Dan & Porscha
Risk-Based Care: Personalized care for better outcomes | Dan & Porscha Daniel Weaver, BSN, RN, Director, Clinical Innovation and Strategy, Biologics by McKesson: When patients are referred to Biologics by McKesson, it's during one of the worst times of their...
Video Transcript: Patient Spotlight – Dan W. and Nurse Porscha Scales
Biologics by McKesson Patient Voice Spotlight - Dan W. Yvonne Sims, Senior Manager, Marketing, Biologics by McKesson: So take us to 2021. Describe your health and what ultimately led to your diagnosis. Dan W., Biologics by McKesson Oncology Patient: I noticed that I...